參考文獻(xiàn)/References:
[1] KAMAL D,ALEXANDRU D O,KAMAL C K,et al.Macroscopic and microscopic findings in avascular necrosis of the femoral head[J].Rom J Morphol Embryol,2012,53(3):557-561.
[2] CUI Q,JO W L,KOO K H,et al.ARCO consensus on the pathogenesis of non-traumatic osteonecrosis of the femoral head[J].J Korean Med Sci,2021,36(10):e65.
[3] KO Y S,HA J H,PARK J W,et al.Updating osteonecrosis of the femoral head[J].Hip Pelvis,2023,35(3):147-156.
[4] 趙德偉,范德超.股骨頭壞死血供障礙分期在股骨頭壞死治療中的指導(dǎo)意義[J].中華損傷與修復(fù)雜志(電子版),2020,15(2):153-155.
[5] ZHAO D,ZHANG F,WANG B,et al.Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults(2019 version)[J].J Orthop Translat,2020,21:100-110.
[6] YUE J,GUO X,WANG R,et al.Reliability and repeatability of 2021 ARCO classification and its guiding significance in treatment of nontraumatic osteonecrosis of the femoral head[J].BMC Musculoskelet Disord,2023,24(1):469.
[7] 中國微循環(huán)學(xué)會骨微循環(huán)專業(yè)委員會.股骨頭壞死臨床診療技術(shù)專家共識(2022年)[J].中國修復(fù)重建外科雜志,2022,36(11):1319-1326.
[8] PINILLA-GRACIA C,HERNÁNDEZ-FERNÁNDEZ A,RODRÍGUEZ-NOGUÉ L,et al.Epidemiology,clinical results and success rate in hip preservation surgery in avascular osteonecrosis of the femoral head[J].Acta Ortop Mex,2020,34(1):16-21.
[9] 中華醫(yī)學(xué)會骨科學(xué)分會關(guān)節(jié)外科學(xué)組,《中國骨與關(guān)節(jié)外科》編輯部,《中華關(guān)節(jié)外科雜志(電子版)》編輯部.股骨頭壞死臨床診療規(guī)范(2015年版)[J].中華關(guān)節(jié)外科雜志(電子版),2015,9(1):133-138.
[10] YOON B H,MONT M A,KOO K H,et al.The 2019 revised version of Association Research Circulation Osseous staging system of osteonecrosis of the femoral head[J].J Arthroplasty,2020,35(4):933-940.
[11] ZHAO D,HUANG S,LU F,et al.Vascularized bone grafting fixed by biodegradable magnesium screw for treating osteonecrosis of the femoral head[J].Biomaterials,2016,81:84-92.
[12] ZHAO K,ZHANG F,QUAN K,et al.Insufficient blood supply of fovea capitis femoris,a risk factor of femoral head osteonecrosis[J].J Orthop Surg Res,2021,16(1):414.
[13] KIM J,LEE S K,KIM J Y,et al.CT and MRI findings beyond the subchondral bone in osteonecrosis of the femoral head to distinguish between ARCO stages 2 and 3A[J].Eur Radiol,2023,33(7):4789-4800.
[14] WANG B,LI L,WANG Y,et al.Digital subtraction angiography and magnetic resonance imaging-based staging of circulatory obstruction in the femoral head during osteonecrosis of the femoral head development[J].Ann Plast Surg,2020,85(6):677-684.
[15] DEWAR D C,LAZARO L E,KLINGER C E,et al.The relative contribution of the medial and lateral femoral circumflex arteries to the vascularity of the head and neck of the femur:a quantitative MRI-based assessment[J].Bone Joint J,2016,98-B(12):1582-1588.
[16] LIU Y,LI M,ZHANG M,et al.Femoral neck fractures:prognosis based on a new classification after superselective angiography[J].J Orthop Sci,2013,18(3):443-450.
[17] ZHENG G S,QIU X,WANG B J,et al.Relationship between blood flow and collapse of nontraumatic osteonecrosis of the femoral head[J].J Bone Joint Surg Am,2022,104(Suppl 2):13-18.
[18] HINES J T,JO W L,CUI Q,et al.Osteonecrosis of the femoral head:an updated review of ARCO on pathogenesis,staging and treatment[J].J Korean Med Sci,2021,36(24):e177.
[19] ZHANG Y,LIU Y W,SUN R B,et al.“Sclerotic Band”type of classification system and measurement of necrotic area for osteonecrosis of the femoral head[J].Medicine(Baltimore),2020,99(36):e22106.
[20] 袁強(qiáng),林繼紅,董一平,等.平均壞死面積指數(shù)和平均穩(wěn)定指數(shù)與壞死股骨頭塌陷進(jìn)展的相關(guān)性分析[J].中國中醫(yī)骨傷科雜志,2022,30(10):23-27.
相似文獻(xiàn)/References:
[1]陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經(jīng)驗(yàn)[J].中醫(yī)正骨,2015,27(10):74.
[2]徐西林,趙永蘭,張曉峰,等.活骨注射液髖關(guān)節(jié)腔灌注對兔股骨頭壞死模型
血管內(nèi)皮生長因子表達(dá)的動態(tài)影響[J].中醫(yī)正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):1.
[3]周勇,任菲菲,豐凡翔,等.血管內(nèi)皮生長因子和骨形態(tài)發(fā)生蛋白2
在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達(dá)[J].中醫(yī)正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):7.
[4]鮑榮華,王國平,夏曉斌,等.鉭棒植入治療非創(chuàng)傷性股骨頭壞死的療效觀察[J].中醫(yī)正骨,2015,27(02):28.
[5]張兵,馬凰富,劉波,等.非創(chuàng)傷性股骨頭壞死的舌象定量研究[J].中醫(yī)正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):8.
[6]李剛,程春生.股骨頭壞死血瘀證癥狀與平樂郭氏正骨方藥藥物組成
最大頻繁關(guān)聯(lián)模式挖掘[J].中醫(yī)正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):21.
[7]李文龍,梅沉成,杜貴強(qiáng),等.微創(chuàng)減壓植骨多孔鉭棒植入治療
ARCOⅡ期非創(chuàng)傷性缺血性股骨頭壞死[J].中醫(yī)正骨,2016,28(02):43.
[8]張磊,金紅婷,童培建.骨健口服液早期干預(yù)非創(chuàng)傷性股骨頭壞死的臨床研究[J].中醫(yī)正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(09):14.
[9]鮑榮華,王國平,夏曉斌,等.直接前入路微創(chuàng)全髖關(guān)節(jié)置換術(shù)治療晚期股骨頭壞死[J].中醫(yī)正骨,2016,28(03):61.
[10]張超,姚晨,沈計榮.微創(chuàng)髓芯減壓打壓支撐植骨術(shù)結(jié)合補(bǔ)腎活血湯口服治療ARCOⅡ、Ⅲ期股骨頭壞死的近期療效觀察[J].中醫(yī)正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(09):20.